Publications by authors named "N Shafi"

Article Synopsis
  • Oral contraceptives (OCs) are commonly used by women for pregnancy control and health issues, but misconceptions about their benefits and risks exist.
  • A study in western Saudi Arabia surveyed women aged 15-49 using an online questionnaire to assess their awareness of OCs.
  • Results showed only 13.6% of participants had excellent knowledge, with most information coming from friends/relatives and physicians, highlighting a connection between reliable sources and knowledge levels.
View Article and Find Full Text PDF

Objective: The main objective was to assess the therapeutic efficacy of selenium alone versus a combination of myo-inositol and selenium (MI + Se) in treating patients with autoimmune thyroiditis (AIT). The study aims to determine which treatment option is more effective in restoring euthyroid state, as indicated by changes in thyroid-stimulating hormone (TSH), T3, T4, thyroid peroxidase antibodies (TPOAb), and thyroglobulin antibodies (TgAb).

Methods: Google Scholar and PubMed databases were searched for randomized controlled trials (RCTs) and observational studies that reported outcomes of combined treatment (MI + Se) in restoring a euthyroid state, specifically comparing it with selenium-only (Se-only) treatment.

View Article and Find Full Text PDF

Dengue fever virus (DENV) poses a significant public health risk in tropical and subtropical regions across the world. Although the dengue fever virus (DENV) exhibits significant genetic diversity and has the potential to evolve, there is a lack of comprehensive research on the comparative genomics and evolutionary dynamics of the virus in Pakistan. Phylogenetic analysis demonstrated the circulation of all four dengue virus serotypes (DENV-1, - 2, - 3, and - 4) with prevalent genotypes III and V within DENV-1, cosmopolitan genotype within DENV-2, genotype III within DENV-3, and genotype I within DENV-4 during 2006-2014.

View Article and Find Full Text PDF
Article Synopsis
  • * A case is presented involving a 51-year-old woman who experienced an acute ischemic stroke, where tenecteplase was given via intraosseous access after standard intravenous access failed.
  • * The patient's stroke symptoms improved significantly within 48 hours post-administration, suggesting that intraosseous delivery of tenecteplase could be a viable alternative when intravenous access is not possible.
View Article and Find Full Text PDF

Cystic fibrosis (CF) is a multisystem, genetic disease with a significantly reduced life expectancy. Despite substantial progress in therapies in the last 10-15 years, there is still no cure. There are dozens of drugs in the development pipeline and multiple clinical trials are being conducted across the globe.

View Article and Find Full Text PDF